Methods and compositions using immunomodulatory compounds in combination therapy

Details for Australian Patent Application No. 2007267928 (hide)

Owner Celgene Corporation

Inventors Corral, Laura; Brady, Helen; Moutouh De Parseval, Laure; Chan, Kyle; Verhelle, Dominique

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007267928

PCT Pub. Number WO2007/139939

Priority 60/808,602 26.05.06 US

Filing date 24 May 2007

Wipo publication date 6 December 2007

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/19 (2006.01)

A61K 31/454 (2006.01)

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

18 December 2008 PCT application entered the National Phase

  PCT publication WO2007/139939 Priority application(s): WO2007/139939

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007267936-Heterobicyclic metalloprotease inhibitors

2007267926-Efficient high-speed electric device using low-loss materials